Nitric oxide synthase as a marker in colorectal carcinoma

American Surgeon

Volumn 67, Issue 7, 2001, Pages 709-713

  Lagares Garcia, Jorge A ^a,b   Moore, Richard A ^a   Collier, Bryan ^a   Heggere, Manjunath ^a   Diaz, Francisco ^a   Qian, Fang ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pathology and Conemaugh Cancer Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN; TUMOR MARKER; NOS2A PROTEIN, HUMAN;

ADULT; AGED; CARCINOMA; CHEMISTRY; COLORECTAL TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PILOT STUDY; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE; VERY ELDERLY; ARTICLE; METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PILOT PROJECTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035403857     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: 10.1177/000313480106700726     Document Type: Article

References (15)

1. Takahashi M, Fukuda K, Ohata T, et al. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 1997;57:1233-7.
2. Ambs S, Merriam WG, Bennet WP, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998;58:334-41.
3. Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90:587-96.
4. Vickers SM, MacMillan-Crow LA, Green M, et al. Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer. Arch Surg 1999;134:245-51.
5. Ho YS, Wang YJ, Lin JK. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cells. Mol Carcinog 1996;16:20-31.
6. Gordon PH, Nivatvongs S. Principles and Practice of the Surgery for the Colon, Rectum and Anus, 2nd Ed. St Louis, MO: Quality Medical Publishing, Inc, 671.
7. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1999. Ca Cancer J Clin 1999;49:8-31.
8. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biologic messenger. Cell 1992;70:705-7.
9. Clancy RM, Abramsson SB. Nitric oxide: A novel mediator of inflammation. Proc Soc Exp Biol Med 1995;210:93-101.
10. Yoshida T, Kaneko Y, Tsukamoto A, et al. Suppression of hepatoma growth and angiogenesis by a fumagilin derivative TNP470: Possible involvement of nitric oxide synthase. Cancer Res 1998;58:3751-6.
11. Xie K, Fidler IJ. Therapy of cancer metastasis by activation of inducible nitric oxide synthase. Cancer Metastasis Rev 1998;17:55-75.
12. Moochhala S, Chhatwal VJ, Chan ST, et al. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996;17:1171-4.
13. Cendan JC, Souba WW, Copeland EM 3rd, Lind DS. Increased L-arginine transport in a nitric oxide-producing metastatic colon cancer cell line. Ann Surg Oncol 1996;3:501-8.
14. Jin Y, Heck DE, DeGeorge G, et al. 5-Fluorouracil suppresses nitric oxide biosynthesis in colon carcinoma cells. Cancer Res 1996;56:1978-82.
15. Colon and Rectum. In: AJCC Cancer Staging Manual, 5th Ed. Philadelphia: Lippincott-Raven Publishers, 1997, pp 83-90.